Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01187810
Title Fenretinide in Children With Recurrent/Resistant ALL, AML, and NHL
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors South Plains Oncology Consortium
Indications

acute lymphoblastic leukemia

acute myeloid leukemia

non-Hodgkin lymphoma

Therapies

Fenretinide

Cytarabine

Methotrexate

Age Groups: child
Covered Countries USA

Facility Status City State Zip Country Details
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field